Become a
ReFermer®
For the brands bold enough to go first.
ReFerm® gives you the edge.
A clinically studied oatbiotic built on Nordic oat fermentation. Join the Gut Barrier Lab and shape what's next.


Referm®
THE FUTURE IS FERMENTED.
Power your products with ReFerm® - clinically studied and easy to formulate.
ReFerm® is a clinically studied oatbiotic. Our patent-pending process, including fermentation, turns Nordic oats into a food-based bioactive matrix of fermentation-derived metabolites, inactivated microbial cells and oat components.
Clinical studies done in humans and experience from 14,000+ Nordic consumers give your brand a strong foundation and a faster path from science to market.
Build your next gut-health product on ReFerm®.
Clinically studied
IN HUMANS, WITH PEER-REVIEWED PUBLICATIONS
14,000+ consumers
NORDIC D2C · SIX YEARS ON THE MARKET
Ready to build on
POWDER OR CAPSULES · NO COLD CHAIN

WHY OATBIOTICS?
Postbiotics are rising.
Oatbiotics are next.
Postbiotics are one of the fastest-moving areas in gut health. Made from inactivated microbial material, they stay stable at room temperature, are simple to formulate and give consistent dosing.
An oatbiotic is a postbiotic made by fermenting oats. ReFerm® is ours: Nordic oats, fermented into a food-based matrix of many fermentation-derived metabolites.
Unique to ReFerm®
Nordic oats
SWEDISH-GROWN, FERMENTED WITH L. PLANTARUM DSM 9843
Patent-pending process
ONE PROCESS, MANY FERMENTATION-DERIVED METABOLITES
A food-based matrix
METABOLITES, INACTIVATED CELLS AND OAT COMPONENTS IN ONE INGREDIENT
The window is open.
According to Future Market Insights, clinical validation is what will give brands the edge.
$2.0B
Projected global postbiotic supplements market by 2036
9.1%
Annual growth, 2026–2036
Source: Future Market Insights, 2026
For brand owners and CDMOs bold enough to go first, Nordic Rebalance is the science-led partner for the gut barrier, backed by ReFerm®.

The Gut Barrier Lab
DARE TO FORMULATE DIFFERENTLY.
One ingredient, many formats.
ReFerm® is supplied as a stable, fermented oatbiotic powder that can be formulated into several finished-product formats, giving brands flexibility in how they bring it to market.
ReFerm® powder can be encapsulated in a vegetable capsule shell for a simple, easy-to-dose supplement format.
Shelf life
As an inactivated, dry powder — not a live-bacteria product — ReFerm® is shelf-stable at room temperature and has a long shelf life. Exact shelf life for a given finished formulation depends on capsule shell, packaging and storage conditions.
Dosage
In finished consumer products, ReFerm® capsules are typically dosed from 500 mg of ReFerm® powder per capsule, with 1–2 capsules per day recommended.
Technical spec
Contains fermentation-derived metabolites, inactivated Lactobacillus plantarum DSM 9843 culture and oat components, and soy lecithin; vegetable (HPMC) capsule shell; vegan formulation; contains trace gluten.
ReFerm® powder can be encapsulated in a vegetable capsule shell for a simple, easy-to-dose supplement format.
Shelf life
As an inactivated, dry powder — not a live-bacteria product — ReFerm® is shelf-stable at room temperature and has a long shelf life. Exact shelf life for a given finished formulation depends on capsule shell, packaging and storage conditions.
Dosage
A consumer product in powder form is typically dosed from 5 g of ReFerm® powder per daily dose, but can be adjusted depending on the consumer need and positioning of the product.
Technical spec
Contains fermentation-derived metabolites, inactivated Lactobacillus plantarum DSM 9843 culture and oat components, and soy lecithin; vegetable (HPMC) capsule shell; vegan formulation; contains trace gluten.
ReFerm® powder can be encapsulated in a vegetable capsule shell for a simple, easy-to-dose supplement format.
Shelf life
As an inactivated, dry powder — not a live-bacteria product — ReFerm® is shelf-stable at room temperature and has a long shelf life. Exact shelf life for a given finished formulation depends on capsule shell, packaging and storage conditions.
Dosage
The effective dose depends on the finished product and target use case, and is defined together with our R&D team during formulation.
Technical spec
Contains fermentation-derived metabolites, inactivated Lactobacillus plantarum DSM 9843 culture and oat components, and soy lecithin; vegetable (HPMC) capsule shell; vegan formulation; contains trace gluten.
Science
Think inside the gut.
Our science builds on more than 20 years of research into Nordic oat fermentation, now focused on how fermentation, the gut flora and the gut barrier work together. ReFerm® is our clinically studied oatbiotic: a postbiotic made from Nordic oats, fermented in our patent-pending process.
Our point of view: we help the bacteria already in the gut protect the gut barrier.
WHAT THE PUBLISHED STUDIES FOUND:
01
Lower gut permeability
Reduced permeability and increased barrier strength resistance in colon biopsies from people with IBS, and in a cell model.
Bednarska et al. 2022, Frontiers in Nutrition (n=30, 14 days)
02
Less mast-cell activity
Reduced mast-cell tryptase and degranulation versus placebo, indicating reduced low grade intestinal inflammation.
Biskou et al. 2024, Frontiers in Medicine (n=30, 14 days)
03
A marker of gut-barrier damage
Strengthened the intestinal barrier in alcohol-related liver fibrosis and cirrhosis, resulting in reduced progression of the fibrosis
Hansen et al. 2025, Nature Communications (n=56, 24 weeks)
Doses in the clinical studies were substantially higher than consumer doses since these studies were conducted on patients with severe diseases. Final product claims are market- and formulation-specific.

“In my research, I found that microbially fermented oats can help reduce inflammation in the gut, while supporting gut-barrier function.”
Dr. Hans Israelsen
Founder & head of R&D
Consumer concept
OatBiotics® - The first ReFermer

You don’t start blind.
14,000+ Swedish consumers have already used ReFerm® through OatBiotics®.
OatBiotics® is our consumer brand in Sweden, the first ReFermer and our hub for consumer insight. It has taken ReFerm® from research into everyday use, and gives us an ongoing dialogue with the people who use it.
For partners, that means real consumer insight from day one: what makes people try a gut-health product, what keeps them coming back, and how to explain oatbiotic science in words people understand.
This real-world experience sits alongside our clinical studies done in humans. We share what we learn through The Gut Barrier Lab, so your launch starts from what already works.
6 years
ON THE NORDIC MARKET
38%
OF CUSTOMERS BUY AGAIN
81%
OF TRUSTPILOT REVIEWS GIVE 4–5 STARS

About us
The future of gut health is our responsibility.
Who we are
Nordic Rebalance is rethinking gut health through Nordic oat fermentation. Inspired by nature and driven by science, we developed ReFerm®: a clinically studied oatbiotic, built for the gut barrier. An oatbiotic is a postbiotic made by fermenting oats, and ours builds on more than 20 years of research.
Why It Matters
The gut barrier is a foundation for better health. When it is weakened, research links it to low-grade inflammation and a range of gut-health concerns. For many people, that means living with gut discomfort every day.
Our approach
Nordic oats. Fermented. Into an oatbiotic. Our patent-pending process turns Nordic oats into a food-based bioactive matrix of fermentation-derived metabolites, inactivated microbial cells and oat components. Our point of view: we help the bacteria already in the gut protect the gut barrier.
WHY WE DO IT
We care about the everyday reality of people living with gut discomfort. And we want to be an easy, dependable and genuinely enjoyable partner for the brands who serve them, whether they are brand owners or CDMOs bold enough to go first.
We believe in better.
IT TAKES GUTS
Go first. Go further.
Tell us what you’re building. We’ll help you get from science to shelf, with samples, documentation and what 14,000+ Swedish consumers have taught us.

